#Rapid Oral Fluid Screening Device Market share

[aimarketresearch]

Rapid Oral Fluid Screening Device Market Size, Share, Trends, Opportunities, Key Drivers and Growth Prospectus

Rapid Oral Fluid Screening Device Market report is an important manuscript for every market enthusiast, policymaker, investor, and market player. The market research and analysis conducted in this report assists clients in forecasting the investment in an emerging market, growth of market share or success of a new product. In addition, this business report endows with a delegate overview of the market where it identifies industry trends, determines brand awareness, potency and insights and provides competitive intelligence. Report contains strong and weak points of the competitors and analysis of their strategies with respect to product and  industry. Rapid Oral Fluid Screening Device Market is the most established tool and hence used widely to generate market research report.

With the complete understanding of business environment that is best suitable for the requirements of the client, Rapid Oral Fluid Screening Device Market business report has been generated. Businesses can also achieve insights into profit growth and sustainability programs with this market report. Market drivers and market restraints explained in this report gives idea about the rise or fall in the consumer demand for the particular product depending on several factors. This market document contains all the company profiles of the major players and brands. Each of the topics is properly elaborated with the in-depth research and analysis for generating an absolute Rapid Oral Fluid Screening Device Market survey report.

Access Full 350 Pages PDF Report @

Data Bridge Market Research analyses that the rapid oral fluid screening device market will exhibit a CAGR of around 14.54% for the forecast period of 2021-2028. Rising prevalence of oral disorders, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies, growing awareness amongst the people regarding the benefits of rapid drug screening and rising expenditure for the development of healthcare infrastructure especially in the developing economies are the major factors attributable to the growth of rapid oral fluid screening device market. Therefore, the rapid oral fluid screening device market value, which was USD 5,485,064.27 million by 2028 from USD 6,867.15 million in 2020.

Rapid Oral Fluid Screening Device Key Benefits over Global Competitors:

The report provides a qualitative and quantitative analysis of the Rapid Oral Fluid Screening Device Market trends, forecasts, and market size to determine new opportunities.

Porter’s Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make strategic business decisions and determine the level of competition in the industry.

Top impacting factors & major investment pockets are highlighted in the research.

The major countries in each region are analyzed and their revenue contribution is mentioned.

The market player positioning segment provides an understanding of the current position of the market players active in the Personal Care Ingredients

Table of Contents: Rapid Oral Fluid Screening Device Market

1 Introduction

2 Global Rapid Oral Fluid Screening Device Market Segmentation

3 Executive Summary

4 Premium Insight

5 Market Overview

6 Rapid Oral Fluid Screening Device Market, by Product Type

7 Rapid Oral Fluid Screening Device Market, by Modality

8 Rapid Oral Fluid Screening Device Market, by Type

9 Rapid Oral Fluid Screening Device Market, by Mode

10 Rapid Oral Fluid Screening Device Market, by End User

12 Rapid Oral Fluid Screening Device Market, by Geography

12 Rapid Oral Fluid Screening Device Market, Company Landscape

13 Swot Analysis

14 Company Profiles

Critical Insights Related to the Rapid Oral Fluid Screening Device Included in the Report:

Exclusive graphics and Illustrative Porter’s Five Forces analysis of some of the leading companies in this market

Value chain analysis of prominent players in the market

Current trends influencing the dynamics of this market across various geographies

Recent mergers, acquisitions, collaborations, and partnerships

Revenue growth of this industry over the forecast period

Marketing strategy study and growth trends

Growth-driven factor analysis

Emerging recess segments and region-wise market

An empirical evaluation of the curve of this market

Ancient, Present, and Probable scope of the market from both prospect value and volume

The major players covered in the rapid oral fluid screening device market report are Abbott., Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings., Quest Diagnostics Incorporated., OraSure Technologies, Inc., Omega Laboratories, Inc., F. Hoffmann-La Roche Ltd, Shimadzu Corporation, Oranoxis, Premier Biotech, Inc., UCP Biosciences, Inc., SCREEN ITALIA Srl, Securetec., MEDACX Ltd., AccuBioTech Co., Ltd., Premier Biotech, Inc., Psychemedics Corporation and American Bio Medica Corporation among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse Trending Reports:

North America Cbct Dental Imaging Market

Myopia Treatment Market

Induced Pluripotent Stem Cells Market

Pneumococcal Vaccine Market

Dupuytrens Disease Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com

[kathansky]

Drug Screening Market: Competitive Insights and Precise Outlook | 2024-2031

Drug Screening Market Overview: A lot of factors, such as geographic growth, segmentation, and market size by value and volume, are taken into account in the SkyQuest Technology Group research to provide a full and accurate analysis of the global Drug Screening market. This outstanding research study was created specifically to provide the most latest data on significant aspects of the global Drug Screening Industry. Numerous market estimates are provided in the analysis, including those for market size, output, revenue, consumption, CAGR, gross margin, price, and other critical factors. The best primary and secondary research methods and tools on the Drug Screening market were used to build it. Numerous research studies are included in it, including ones on pricing analysis, production and consumption analysis, company profile, and manufacturing cost analysis.

Global Drug Screening Market size was valued at USD 8.9 billion in 2022 and is poised to grow from USD 10.37 billion in 2023 to USD 35.18 billion by 2031, growing at a CAGR of 16.5% during the forecast period (2024-2031). The competitive environment is a crucial element that every key factor needs to be aware of. The study explains the market's competitive landscape so that readers may gauge the degree of both domestic and global rivalry. Additionally, market researchers have provided summaries of each significant firm in the global Drug Screening industry, taking into consideration crucial elements including operational areas, production, and product portfolio. When analyzing the organizations in the study, significant factors including business size, market share, market growth, revenue, production volume, and profitability are also taken into account. The study report uses both qualitative and quantitative data to offer a thorough view of the market. It examines and forecasts the global market in a number of critical industries. The research provides a thorough overview of the industry by segmenting the Drug Screening market into groups based on application, end-user, and location. A thorough research of each market segment was conducted, taking into consideration current and upcoming market trends.

Chance to get a free sample @ https://www.skyquestt.com/sample-request/drug-screening-market  Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Drug Screening Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.

Product & Service

Drug Screening Services [Laboratory Testing Services, On-site Testing Services], Drug Screening Products [Analytical Instruments (By Type {Breathalyzers “Fuel-cell Breathalyzers, Semiconductor Breathalyzers, Other Breathalyzers”, Immunoassay analyzers, Chromatography instruments}, By Modality {Hand-held drug screening products, Benchtop drug screening products}, Rapid Testing Devices (Urine testing devices {Drug testing cups, Dip cards, Drug testing cassettes}, Oral fluid testing devices), Consumables {Assay kit, Sample collection devices, Calibrators and controls, Other consumables}]

Sample Type

Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples

Drug Type

Cannabis, Alcohol, Cocaine, Opioids, Amphetamine and Methamphetamine, Other Drugs

End User

Drug Testing Laboratories, Workplaces, Criminal Justice Systems and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges, Other End Users

Get your Customized report @ https://www.skyquestt.com/speak-with-analyst/drug-screening-market 

Following are the players analyzed in the report:

Quest Diagnostics (US) 

Abbott (US) 

OraSure Technologies Inc. (US) 

Alfa Scientific Designs Inc. (US) 

Thermo Fisher Scientific, Inc. (US) 

Drägerwerk AG & Co. KGaA (Germany) 

Lifeloc Technologies, Inc. (US) 

MPD Inc. (US) 

Omega Laboratories, Inc. (US) 

Premier Biotech, Inc. (US) 

Psychemedics Corporation (US) 

F. Hoffmann-La Roche Ltd. (Switzerland) 

Shimadzu Corporation (Japan) 

Siemens Healthineers AG (Germany) 

American Bio Medica Corporation (US) 

ACM Global Laboratories (US) 

CareHealth America Corp. (US) 

Clinical Reference Laboratory, Inc. (US) 

Intoximeters (US) 

Sciteck, Inc. (US) 

AccuSourceHR, Inc. (US) 

Cordant Health Solutions (US) 

Intoxalock (US) 

Millennium Health (US) 

AdvaCare Pharma (US)

Motives for purchasing this report- - A full understanding of customer experiences, upcoming trends, and growth drivers may be obtained by market category analysis. -Drug Screening Market participants will be able to quickly decide on their course of action in order to achieve a competitive advantage thanks to the essential information provided in this area. The factors affecting the sales prospect are carefully examined by SkyQuest Technology Group across several important categories. - Analysing market categories can provide detailed insights into consumer experiences, upcoming trends, and growth-promoting factors. A thorough analysis of market manufacturing trends is a crucial component of the study. -These observations offer crucial information on the ways in which market participants are reacting to the most recent developments that are oversaturating the market. -An in-depth analysis of the numerous organic

Buy your full Market Report now: https://www.skyquestt.com/buy-now/drug-screening-market  FAQs:

1. What are the main vendors' points of strength and weakness?

2. What are the primary business plans of the leading important players for the near future?

3. What will the market size and growth rate be for Drug Screening in the upcoming year?

4. Which prevailing global trends are affecting the Drug Screening market shares of the leading regions? What effect does Covid19 have on the Industry right now?

[anitha-kurva]

Rapid Oral Fluid Screening Device Market Size, Share, Industry, Forecast and Outlook (2024-2031)

The Global “Rapid Oral Fluid Screening Device Market” is expected to grow at a high CAGR during the forecast period (2024-2031).

Read More:https://shorturl.at/GFNb6

[industryforecastnews]

Drug Testing Market Size To Reach USD 8.45 Billion By 2030

Drug Testing Market Growth & Trends

The global drug testing market size is expected to reach USD 8.45 billion by 2030, expanding at a CAGR of 4.8% from 2024 to 2030, according to a new report by Grand View Research, Inc.. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period. 

Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.

For instance, in June 2019, Quidel Corporation received the U.S. FDA’s 510(k) clearance to market its fluorescence immunoassay—Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing to help courts & government agencies to monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.

Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power to conduct random roadside drug testing of drivers to reduce impaired driving in the country. The new bill allows usage of oral fluid tests to check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis to ensure safe air travel.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/drug-testing-market

Drug Testing Market Report Highlights

By product type, the consumables segment dominated the market in 2023, owing to its repetitive use to conduct substance abuse screening

Based on sample type, the urine samples segment accounted for the largest revenue share in 2023, as it is the most common method of sample collection

Increased unemployment and economic crisis due to the Covid-19 pandemic has made people more susceptible to substance abuse, thus created lucrative opportunities in the market

The legalization of marijuana for medicinal as well as recreational use in several countries is anticipated to change the current scenario and may create demand for innovative testing solutions

Stringent privacy rights in some countries are likely to limit substance abuse testing at workplaces, impeding market growth

In Asia Pacific, the market is expected to witness lucrative growth over the forecast period as a result of the growing demand for substance abuse testing from emerging economies, such as China and India

Drug Testing Market Segmentation

Grand View Research has segmented the global drug testing market based on product, sample, drug, end-use, and region:

Drug Testing Product Outlook (Revenue, USD Million, 2018 - 2030)

Consumables

Instruments

Rapid Testing Devices

Services

Drug Testing Sample Outlook (Revenue, USD Million, 2018 - 2030)

Urine Samples

Oral Fluid Samples

Hair Samples

Other Samples

Drug Testing Drug Outlook (Revenue, USD Million, 2018 - 2030)

Alcohol

Cannabis/Marijuana

Cocaine

Opioids

Amphetamine & Methamphetamine

LSD

Others

Drug Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)

Drug Testing Laboratories

Workplaces

Hospitals

Others

Drug Testing Regional Outlook (Revenue in USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Regional Insights

North America drug testing market dominated and accounted for a 39.5% share in 2023. This high share is attributable to the local presence of key global market players, such as Bio-Rad Laboratories, Laboratory Corporation of America Holdings, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd. and others. Moreover, the growth of the drug testing market in North America can majorly be attributed to the increasing incidence of abuse, stringent government regulations, and active screening programs. The governments are actively engaged in controlling the consumption of hazardous drugs to minimize the cost burden associated with it. In addition, the authorities are focusing on formulating new policies. For instance, in September 2023, San Francisco Human Services Agency (SFHSA) announced a new initiative that would need people suffering from substance use disorder who wish to gain access to county funds to enroll in treatment and services.

List of Key Players in Drug Testing Market

Quest Diagnostics Incorporated

Abbott

F. Hoffmann-La Roche Ltd.

Quidel Corporation

Thermo Fisher Scientific, Inc.

Siemens Healthcare GmbH

Bio-Rad Laboratories, Inc.

Agilent Technologies, Inc.

Laboratory Corporation of America Holdings

Clinical Reference Laboratory, Inc.

Cordant Health Solutions

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/drug-testing-market  

[efrost]

Drugs of Abuse Testing Unidentified Segments – The Biggest Opportunity Of 2022

Global Drugs of Abuse Testing Market Report from AMA Research highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, players market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved profitability. In addition, the study helps venture or private players in understanding the companies in more detail to make better informed decisions. Major Players in This Report Include

F. Hoffmann-La Roche Ltd. (Switzerland)

Thermo Fisher Scientific Inc. (United States)

Drägerwerk AG & Co. KGaA (Germany)

Laboratory Corporation of America Holdings (United States)

Siemens Healthineers (Germany)

Abbott Laboratories (United States)

Danaher Corporation (Beckman Coulter, Inc.) (United States)

Express Diagnostics International Inc. (United States)

Shimadzu Corporation. (Japan)

Quest Diagnostics (United States)

Drugs of Abuse Testing is a method to detect the drugs present in a human body by the help of saliva, urine, blood, and sweat. This testing compromise of devices by which we can check or measure the intake of drugs in a human body and can be conducted at home or laboratories. According to United Nations Office on Drugs and Crime 246 million number of people of the age group from 15 to 64 used drugs and by National Survey, 9.8 million number of people across the globe suffered from mental illness due to the consumption of high drugs. Drugs that are majorly causing the addiction are cocaine, heroin, and marijuana among others. Increasing consumption of drugs by adults coupled with rising illness due to the consumption of drugs is driving the market for drugs of abuse testing.

Market Drivers  Increasing More Consumption of Drugs among Adults across Globe

Rising Advancements in Technology of Analyzers

Increasing Availability of Forbidden Drugs

Increase in Impact of Drug and Alcohol Abuse on Public Health

Market Trend  Adoption of Drug Testing At the Workplace

Highly Usage of Drug of Abuse Tests For Legal and Medical Purposes

Opportunities  Increasing Number of Toxicological Laboratories in both Developed and Developing Countries

Rising Demand for Drug Abuse Testing Among Private Employers

Growing Emphasis on Work Place Screening Among the Urban Populations

Challenges  Concern Related To the Inability to Detect Low-Dose Designer Drugs

Issue Related To Accuracy and Specificity Concerns Related To Breathalyzers

The Drugs of Abuse Testing market study is being classified by Type (Psychostimulants, Narcotic, Hallucinogens, Sedatives, Others), Application (Hospitals, Diagnostics Laboratories, Forensic Laboratories, Others), Rapid Testing Device (Urine Testing, Oral Fluid Testing), Testing Type (Pain Management Testing, Criminal Justice Testing, Work Place Screening), Sample Type (Saliva, Breath, Urine, Blood, Hair and Sweat), Analyzers Type (Immunoassays, Chromatographic Devices, Breath Analyzers) Presented By

AMA Research & Media LLP

[karishmamulani]

Rapid Oral Fluid Screening Device Market Size, Trends, Share, Research Report

The global rapid oral fluid screening device market size is predicted to reach USD 24.08 billion by 2027 according to a new study by Polaris Market Research. The report “Rapid Oral Fluid Screening Device Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Alcohol, Marijuana, Opioids, Cocaine, Amphetamine, Methamphetamine, Benzodiazepines); By Forms (Cassettes, Swabs, Strips); By End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Private Employers, Home care Setting); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

In trend with the developing business models in healthcare sector, development of effective, efficient and productive products is on a significant surge, coupling with increasing favorable reimbursements and approvals by the government. Rising strong product pipelines for the research & development of novel rapid oral fluid screening devices also contribute a remarkable proportion towards surging the market growth globally over the forecast period.

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/rapid-oral-fluid-screening-device-market/request-for-sample

Furthermore, as the technology is becoming easy-to-develop and subject to a smaller number of regulations, the market is witnessing less entry hurdles for new entrants. Additionally, rapid oral fluid has ability to diagnose drug consumed in the body in less than one day and cannabis consumed in less than four hours after the testing time, hence, propelling the growth of rapid oral fluid screening devices, globally over the projected period.

Rapid oral fluid screening devices provide a wide range of screening abilities such as marijuana, cocaine, methamphetamine, and opioids are expected to drive rapid oral fluid screening device market growth over the forecast period. In addition, the growing need for drug screening across the regions owing to increasing consumption of illegal narcotics is expected to drive the demand for these devices in the coming years.

Get Discount on this Research Report : https://www.polarismarketresearch.com/industry-analysis/rapid-oral-fluid-screening-device-market/request-for-discount-pricing

The global rapid oral fluid screening device market players include OraSure Technologies, Inc., Oranoxis Inc., Guangzhou Wondfo Biotech Co., Ltd, UCP Biosciences, Inc., MEDACX Limited, Screen Italia Srl, and AccuBioTech Co. Ltd., among others. Moreover, developing and commercializing products that evaluate adherence to HIV medications, enhancing its product offerings to include additional diagnostic offerings, and building new infrastructure also adds towards the growth of the organizations.

Read More : https://www.prnewswire.com/news-releases/rapid-oral-fluid-screening-device-market-size-usd-24-08-billion-by-2027--cagr-20-7--polaris-market-research-301212427.html

[globalmarketsresearchreports]

Global Drug Screening Market Highlights and Forecasts to 2031

Drug Screening Global Market Report 2022 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography. It covers the historic period – 2016-2021, and the forecast period – 2022-2026, with additional forecasts for 2026-2031. The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

TBRC’s market report includes a chapter on the COVID-19 impact on the drug screening industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it. With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected drug screening market growth numbers from 2022-2031.

Request a Sample of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

The global drug screening market size is expected to grow from $5.80 billion in 2021 to $6.58 billion in 2022 at a compound annual growth rate (CAGR) of 13.53%. The global drug screening market share is expected to grow to $10.66 billion in 2026 at a CAGR of 12.81%.

View more on the report:

The Drug Screening Global Market Report 2022-31 by The Business Research Company evaluates drug screening market size, growth rate, drivers, drug screening industry trends, and major companies.

The drug screening market segments in the report are:

1) By Product: Rapid Testing Devices, Consumables, Others

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Others

3) By End-User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

The table of contents in TBRC’s drug screening market report includes:

1. Executive Summary

2. Market Characteristics

3. Market Trends And Strategies

4. Impact Of COVID-19

5. Market Size And Growth

6. Segmentation

7. Regional And Country Analysis

.

.

.

27. Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis

About The Business Research Company:  The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 28+ countries globally.  

Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Contact Information:  The Business Research Company  Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

Check out our Blog: http://blog.tbrc.info/

[healthcare-market]

Drugs of Abuse Testing Market to Perceive Substantial Growth by the End 2027

Transparency Market Research (TMR) has published a new report titled, ‘Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global drugs of abuse testing market was valued at US$ 4.6 Bn in 2018 and is projected to expand at a CAGR of 5.7% from 2019 to 2027.

Overview

· Illicit drug consumption is largely a youth phenomenon, gradually increasing through teens and reaching peak in persons aged 18 to 25. Abuse of drugs and alcohol has negative consequences on society and poses a significant burden on the workplace and health care systems.

· North America dominated the global drugs of abuse testing market in 2018 and the trend is anticipated to continue during the forecast period. Highly structured health care industry, increased usage of illicit drugs, and introduction of the Affordable Care Act in the U.S. are expected to drive the market in North America.

· Moreover, North America is also likely to be a highly lucrative market for drugs of abuse testing and it is expected to expand at a high CAGR during the forecast period

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54426

Rise in law enforcement spending for illicit drug interdiction and growing impact of drug and alcohol abuse on public health to Drive Market

· Governments across the world have increased expenditure on law enforcement agencies aimed toward drug interdiction through mandatory screening of potential illicit drug abusers. For instance, in the U.S., the Office of National Drug Control Policy spent US$ 31.1 Bn for illicit drug control in 2015 in order to reduce drug use and its consequences.

· Substance abuse has high impact on the health of individuals and their families. According to United Nations World Drug Report (2016), an estimated 1 in 20 adults aged between 15 and 65 used at least one drug in 2014. Moreover, over 29 million drug users suffer from substance use disorders leading to high health consequences.

Request a Sample of Drugs of Abuse Testing Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=54426

Analyzers Segment to Dominate Market

· Based on product type, the global drugs of abuse testing market has been divided into analyzers, rapid testing devices and consumables. The analyzers segment has been bifurcated into immunoassays analyzers, chromatographic devices and breath analyzers.

· The analyzers segment dominated the global drugs of abuse testing market in 2018 and the trend is projected to continue during the forecast period. Increase in use of analyzers to accelerate the growth of the segment. Increase in the popularity of breath analyzers is also major factor for to boost the market growth.

· Further, the rapid testing devices segmented into urine testing devices and oral fluid testing devices and consumables divided into fluid collection devices and others.

Request for Analysis of COVID19 Impact on Drugs of Abuse Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=54426

Work Place Screening to be Highly Lucrative Segment

· In terms of testing type, the global drugs of abuse testing market has been classified into pain management testing, criminal justice testing and work place screening.

· The work place screening of abuse testing segment dominated the drugs of abuse testing market owing to rise in trend of evaluating employees for drug abuse testing at workplaces in order to enhance productivity in business and avoid workplace related injuries.

North America to Dominate Global Market

· In terms of region, the global drugs of abuse testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global drugs of abuse testing market in 2018, followed by Europe.

· North America accounted for major share of the global drugs of abuse testing market in 2018, increased consumption of illicit drugs and the penetration of insurance plans for costly diagnosis tests, making it one of the largest markets in terms of revenue

· According to CDC, approximately 10.6% of the U.S. population aged 12 years and above consumed illicit drugs in 2016.

Enquiry before Buying Drugs of Abuse Testing Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=54426

Competitive Landscape

· The global Drugs of abuse testing market is fragmented in terms of number of players. Key players in the global market include Alere Inc., Laboratory Corporation of America Holdings, Roche Diagnostics, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Siemens Healthineers, Express Diagnostics International Inc. and Shimadzu Corporation among others

More Trending Reports by Transparency Market Research:

Mobile Hospitals Market

https://www.prnewswire.com/news-releases/mobile-hospitals-market-to-expand-at-cagr-of-10-1-key-role-played-during-covid-19-pandemic-strengthens-growth-prospects-finds-tmr-301388801.html

Surgical Glue Market

https://www.prnewswire.com/news-releases/surgical-glue-market-size-to-surpass-us-2-9-billion-by-2027-end-says-tmr-301395333.html

Veterinary Supplements Market

https://www.prnewswire.com/news-releases/veterinary-supplements-market-to-be-worth-us-13-76-billion-by-2031--increasing-demand-for-natural-supplements-and-products-with-prebiotic-content-to-bolster-market-growth-says-tmr-301398612.html

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

[itssashasharma]

Global Drug Screening Market worth $ 10.0 billion : Indicates Impressive Growth Rate In Chromatography Industry

According to the new market research report ” Drug Screening Market by Product (Consumables, Urine testing devices, Analytical, Breathalyzer, Chromatography) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) – Global Forecast to 2025″, published by MarketsandMarkets™ , global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3%.

Major Growth Drivers:

Growth in this market is attributed to the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches.

Expected Revenue Growth:

[192 Pages Report] The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3%.

COVID-19 impact on the drug screening market

COVID-19 has resulted in significant disruptions to businesses and economic activities globally and is expected to have a short-term negative impact on the drug screening market due to limited or non-availability of medical facilities/treatment centers, harm reduction service providers, and the fear of infection transmission. To reduce the strain on the healthcare system and decrease disease transmission, various governments worldwide provided guidelines to postpone or delay non-essential medical and surgical procedures.

Browse in-depth TOC on “Drug Screening Market”192 – Tables35 – Figures192 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

The rapid testing devices segment will witness the highest growth during the forecast period.

Based on product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables. Rapid testing devices market is further subsegmented into urine testing devices and oral fluid testing devices. The urine testing devices segment is expected to account for the largest market share in 2019. However, the oral fluid testing devices segment is projected to register highest CAGR during the forecast period. The high growth in this segment is attributed to the benefits it offers such as shorter detection window, non-invasive nature, and low risk of sample tampering.

North America was the largest regional market for drug screening market in 2019.

The drug screening market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest regional segment of the overall market, followed by Europe. The dominance of the North American market is attributed to factors such as rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening, and growing burden of accidents due to unsafe levels of alcohol consumption.

Request for sample pages :  https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773

Key Market Players

The prominent players operating in this market include LabCorp (US), Quest Diagnostics (US), Alere (US), OraSure (US), Alfa Scientific Designs (US), Thermo Fisher Scientific (US), Drägerwerk (Germany), LifeLoc (US), MPD Inc. (US), Omega Laboratories (US), Premier Biotech (US), Psychemedics (US), Roche (Switzerland), Shimadzu (Japan), and Siemens Healthineers (Germany).

[aimarketresearch]

Biosimilar Market Size, Share, Key Growth Drivers, Trends, Challenges and Competitive Landscape

Data Bridge Market research has recently issued comprehensive industry research on Global Biosimilar Market which includes growth analysis, regional marketing, challenges, opportunities, and drivers analysed in the report.

Besides, Biosimilar market report studies market growth opportunities and restraining factors. The geographical division of this market analysis report offers data that gives an idea of the revenue of the companies and sales figures of the market growth. The market report also contains the drivers and restraints for the Biosimilar market that are obtained with the help of SWOT analysis, and also shows all the recent developments, product launches, joint ventures, mergers and acquisitions by the several key players and brands with their systemic company profiles, that are driving the market.

Access Full 350 Pages PDF Report @

Data Bridge Market Research analyses that the global biosimilar market which was USD 37,270.20 million in 2022, is expected to reach USD 343,520.90 million by 2030, and is expected to undergo a CAGR of 32.00% during the forecast period 2023-2030. “Oncology” dominates the product segment of the global biosimilar market owing to the owing to the increase in number of research studies, increasing research and development activities by key players focused on oncology and advancements in healthcare technologies. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

TABLE OF CONTENTS

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers and Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Key Questions Answered with this Study

1) What makes Biosimilar Market feasible for long term investment?

2) Know value chain areas where players can create value?

3) Teritorry that may see steep rise in CAGR & Y-O-Y growth?

4) What geographic region would have better demand for product/services?

5) What opportunity emerging territory would offer to established and new entrants in Biosimilar Market?

6) Risk side analysis connected with service providers?

7) How influencing factors driving the demand of Biosimilarin next few years?

8) What is the impact analysis of various factors in the Global Biosimilar Market growth?

9) What strategies of big players help them acquire share in mature market?

10) How Technology and Customer-Centric Innovation is bringing big Change in Biosimilar Market?

Some of the major players operating in the global biosimilar market are:

Novartis AG (Switzerland)

 Orion Pharma AB (Sweden)

 Pfizer Inc. (U.S.)

Samsung Bioepis. (South Korea)

 Coherus BioSciences, Inc. (U.S.)

 Amgen Inc. (U.S.)

Eli Lilly and Company (U.S.)

 Takeda Pharmaceutical Company Limited. (Japan)

 Bristol-Myers Squibb Company (U.S.)

 Merck KGaA (Germany)

 Teva Pharmaceutical Industries Ltd. (U.S.)

 Biocon. (India)

 Bayer AG (Germany)

 AbbVie Inc. (U.S.)

 Allergan (Ireland)

 Dr. Reddy’s Laboratories Ltd. (India)

 Boehringer Ingelheim International GmbH. (Germany)

 Biogen (U.S.)

Browse Trending Reports:

Prenatal Testing And New Born Screening Market

Rapid Oral Fluid Screening Device Market

North America Eclinical Solutions Market

Medical Tuning Fork Market

North America Cbct Dental Imaging Market

Myopia Treatment Market

Induced Pluripotent Stem Cells Market

Pneumococcal Vaccine Market

Dupuytrens Disease Market

Mitogen Activated Protein Kinase Mapk Inhibitors Therapeutics Market

Neonatal Seizures Drugs Market

Chikungunya Treatment Market

Sickle Cell Disease Treatment Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com

[blueweave]

Global Drug Screening Market Size and Share is Projected to Reach Worth USD 14.14 Billion in 2027 | BlueWeave

A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global drug screening market was worth USD 4.47 Billion in the year 2020 and anticipated to grow at a CAGR of 18.6% during 2021-2027 (forecast period). Concerns about growing alcohol and drug abuse cases around the world have contributed to the market's growth. The drug screening market has also grown in popularity due to increased demand from institutions such as workplaces, schools, and the sports industry. Drug testing is performed to screen athletes for drug misuse. It is also used for screening employers before hiring or random inspection. Rising public awareness about the dangers of drug usage, as well as government funding for drug screening programs, have all contributed to the market's growth.

The drug screening market has also grown as a result of new and diverse drug screening applications, as well as creative product developments. This has resulted in better services for customers, such as faster and more accurate results. However, the ongoing controversy over invasion of privacy as a result of drug screening has reduced market demand. The banning of alcohol consumption in many Islamic countries has also affected the geographical expansion of the drug and screening market across the globe. The drawback of the breathalyzer test's inefficiency has also resulted in a reduction in drug and screening market growth.

Innovative Products Expanding Market Opportunities

The drug screening industry is experiencing a surge in demand as a result of the availability of novel goods, which has enhanced consumer satisfaction. For example, the innovative organ-on-a-chip system has revolutionized the drug screening process and is also aiding in clinical studies. It is a microfluidic chip that can stimulate any organ like the liver, gut, and even tumors on a chip. Fingerprint-based testing has also emerged as a novel breakthrough in this market and has gained prominence throughout the pandemic. Fingerprint-based testing is highly preferred as they are non-invasive, hygienic, facilitates social distancing, and requires no specific preparation for sample collection. The growing opportunities offered by such innovations are likely to replace urine, hair, and blood samples in the future.

Concern Over Substance Abuse Creating Driving Demand

The rate of increased drug and alcohol consumption all over the globe is an alarming issue. According to the American Academy of Child & Adolescent Psychiatry, alcohol and drug abuse accounts for approximately 50% all deaths in the 15–24 age group. Among teenagers, the figures are alarming. Every day about 28 people in the U.S. die due to drunk-driving-related accidents, i.e., 1 person in every 52 minutes. Such alarming numbers have resulted in a greater awareness of the dangers of drug and alcohol use. This has created a demand for the drug screening market across the globe. Additionally, many governments are providing funds for testing programs and passing stringent laws to reduce these alarming numbers.

Request to Download Free Sample Report: https://www.blueweaveconsulting.com/drug-screening-market-report/report-sample

Urine Sample Segment Dominates the Market

The global drug screening market, based on sample type, is categorized into oral fluid,hair, breath, urine, and other samples. The urine sample segment held the largest market share in 2020. The driving factor for the growth of this segment is lost cost procedure and reliability of results. They are used in drug screening for the presence of cocaine, marijuana, and opiates. They are demanded in many workplace organizations to conduct screening procedures before hiring new employees. As a result of this demand, this segment has a sizable market share in the worldwide drug screening market.

Impact of COVID-19

The outbreak of the coronavirus pandemic has had a negative impact on the growth of the drug screening market. Many sectors' industrial activity has been significantly hampered as a result of the nationwide lockdown and temporary closures. The closure of manufacturing, processing, and commercial organizations has also impacted the drug screening market's product availability. Travel bans and trade restrictions have widened the gap between supply and demand for the market. Furthermore, the focus of the healthcare sector, majorly on COVID-related cases, has also reduced the demand for the drug screening market. However, the rapid testing devices segment of this market has found its massive application in the diagnosis of coronavirus.

North America Contributing Largest Market Share

Based on region, the Drug Screening Market is categorized into North America, Europe, the Asia-Pacific, Latin America, and the Middle East & Africa. North America dominated the global market with the largest share in 2020. Rising drug abuse cases in this region have prompted the government to release funds for spreading awareness related to drug testing programs, which in turn is driving the growth of the marker. For instance, the Drug Testing Center of America has focused its efforts on providing cost-effective drug testing services to its population. During the projected period, however, the Asia-Pacific region is predicted to contribute the most to the worldwide drug screening market. The alarming rise in drug and alcohol use in this region has created market demand. Around 147,660 cases of drug abuse were reported in medical centers from Taiwan alone. As per the China Real-Time report, about 51% of teens are involved in alcohol consumption.

Competitive Landscape

The Drug Screening Market is highly competitive and fragmented with international and regional players. The key players dominating the market are LabCorp, Quest Diagnostics, Abbott Rapid Diagnostics, OraSure Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Dragerwerk AG, Lifeloc Technologies, MPD Inc., Omega Laboratories, Premier Biotech Inc., Psychemedics Corporation, Roche AG, Shimadzu Corporation, Siemens Healthcare, BioMerieux SA, Synergy Health plc., CareHealth America Corporation, Biomedical Diagnostics, Agilent Technologies, and other prominent players. Many firms are collaborating with government and agencies to raise awareness about substance abuse. This has improved the consumer reach of this market and contributed to the benefit of society.

Don’t miss the business opportunity of the global drug screening market. Consult our analysts to gain crucial insights and facilitate your business growth.

The report's in-depth analysis provides information about growth potential, upcoming trends, and theglobal drug screening market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global drug screening market ­ along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Contact Us:

BlueWeave Consulting Pvt Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com

https://www.linkedin.com/company/blueweaveconsulting/

[anitakumarigrewal]

Rise in Consumption of Drugs among Adults Expected to Drive Global Drug of Abuse Testing Market: Ken Research

Drugs for abuse testing devices offer various testing methods to detect drugs present in the human body by analyzing blood, urine, saliva, and sweat. The drug for abuse testing devices market comprises kits & devices that help in measuring drug intake. These tests can be conducted at home and in laboratories. The test uses immunoassay for screening different samples and includes the verification of screening results by definitive analytical techniques for instance spectrometry and chromatography. Drugs such as anabolic steroids, cocaine, methamphetamine, marijuana, heroin, diazepam, lorazepam, and inhalants tend to cause addiction, various health problems, and severe illness in adults.

According to study, “Global Drug of Abuse Testing Market: Market Segments: By Product Type (Analyzers, Rapid Testing Devices, and Consumables); By Sample Type(Saliva, Urine, Blood and Others); By End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories and Others);and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030” the key companies operating in the global drug of abuse testing market are Merck KGaA, Danaher Corporation, Sonic Healthcare Ltd., Siemens AG, Drägerwerk AG & Co. KGaA, bioMérieux S.A., Express Diagnostics Int'l, Inc., Waters Corporation, Quest Diagnostics Inc., Roche Holding AG, Laboratory Corporation of America Holdings, Abbott Laboratories, Alere Inc., Randox Laboratories Ltd., Bio-Rad Laboratories, Inc., Psyche medics Corporation, and Thermo Fisher Scientific Inc.

The drug of abuse testing market market is driven by rise in advancements in technology of analyzers, followed by increase in impact of drugs & alcohol abuse on public health, rise in consumption of drugs among adults across globe and increase in availability of forbidden drugs. However, lack of global standard definition of a problem drug user, high prices related to drug testing and lack of awareness regarding the availability of advanced drug testing devices may impact the market. Moreover, rise in demand for drug abuse testing among private employers, increase in number of toxicological laboratories and growth in emphasis on work place screening among the urban populations are key opportunities for market. Furthermore, highly usage of drug of abuse tests for legal & medical purposes and growth in adoption of drug testing at the workplace are major trends for market.

Based on type, drug of abuse testing market market is segmented as Narcotic, Psycho stimulants, Sedatives, Hallucinogens and others. Based on testing type, market is segmented as criminal justice testing, pain management testing and work place screening. Based on analyzers type, market is segmented as chromatographic devices, immunoassays and breath analyzers. Based on rapid testing device, market is segmented as oral fluid testing and urine testing. Based on sample type, market is segmented as breath, saliva, blood, urine, sweat and hair. In addition, based on application, market is segmented as forensic laboratories, diagnostics laboratories and hospitals.

Based on geography, the North-American region holds major share in global drug of abuse testing market market owing to rise in consumption of drugs, strong presence of drug of abuse testing device companies and progressing regulatory framework in the region. The European market is anticipated to be the second-largest due to increase in government initiatives to curb abuse and surge in alcohol-related accidents over the forecast period. Additionally, the Asian-Pacific region is also anticipated to witness higher growth rate as a result of rise in alcohol consumption coupled with strict government rules & regulations about testing drug consumption during the forecast period.

For More Information, click on the link below:-

Global Drug of Abuse Testing Market Research Report

Related Report:-

Global Drug of Abuse Testing Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

ankur@kenresearch.com

+91-9015378249

[covidimpact]

Drug Abuse Testing Market Size, Status, Growth | Industry Analysis Report 2020-2027

The Drug Abuse Testing Market 2021 research report gives emerging industry data, global segments and regional outlook. This report covers up all details such as size, share, value, growth, restraints, and opportunities for the year 2020 to 2027. The report generated using various analysis tools like porter’s five forces model, market attractiveness and value chain. The report gives comprehensive review of the global market helping to club revenue generation and profitable business to transform client’s success.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the drug abuse testing market include OraSure, Alfa Scientific Designs, Lifeloc, MPD, Inc., Premier Biotech, Shimadzu, Psychemedics, SureHire, CannAmm, and Omega Laboratories.S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Get more information on "Global Drug Abuse Testing Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/drug-abuse-testing-market/download-sample

Market Dynamics

The rapid increase in the number of substance abusers and people consuming illicit drugs will stimulate this market's growth. Mandatory guidelines for workplaces and schools to conduct drug abuse testing on suspicious candidates will benefit market growth. Extensive use of drug abuse testing for medical screening, Legal or forensic information, Sports/athletics testing, and in Monitoring pain medication use will boost the market growth. An increase in the mortality rate due to drug overdose among the upper class and the enforcement of stringent regulations for A&D testing in various fields, such as aviation, railroad, transportation, and mass transit, will be a market booster. The barriers hindering this market's growth are the high costs of testing and the testing mechanisms' in comprehensive nature. The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give inclusive assessment of each segment in the global market of drug abuse testing.

Browse Global Drug Abuse Testing Market Research Report with detailed TOC at https://www.valuemarketresearch.com/report/drug-abuse-testing-market

Market Segmentation

This section of the drug abuse testing market report  provides detailed data on the segments by analyzing them grographically, thereby assisting the strategist in identifying the target demographics for the respective product or service. By Product & Services

Analyzers

Consumables

Rapid     Testing Devices

Laboratory     Services

By Sample Type

Urine

Oral     Fluid (Saliva)

Hair

Breath

Others

By End User

Workplaces     & Schools

Criminal     Justice Systems and Law Enforcement Agencies

Research     Laboratories

Hospitals

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for aerosol valve market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Purchase Complete Global Drug Abuse Testing Market Research Report at https://www.valuemarketresearch.com/contact/drug-abuse-testing-market/buy-now

About Us:

Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.

We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.

Contact:

Value Market Research

401/402, TFM, Nagras Road, Aundh, Pune-7.

Maharashtra, INDIA.

Tel: +1-888-294-1147

Email: sales@valuemarketresearch.com

Website: https://www.valuemarketresearch.com

[karishmamulani]

Rapid oral fluid screening device Market Recent Trends, Growth, Top Manufacturers Analysis, Business Opportunities and Demand

The global rapid oral fluid screening device market size is predicted to reach USD 24.08 billion by 2027 according to a new study by Polaris Market Research. The report “Rapid Oral Fluid Screening Device Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Alcohol, Marijuana, Opioids, Cocaine, Amphetamine, Methamphetamine, Benzodiazepines); By Forms (Cassettes, Swabs, Strips); By End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Private Employers, Home care Setting); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 In trend with the developing business models in healthcare sector, development of effective, efficient and productive products is on a significant surge, coupling with increasing favorable reimbursements and approvals by the government. Rising strong product pipelines for the research & development of novel rapid oral fluid screening devices also contribute a remarkable proportion towards surging the market growth globally over the forecast period.

 Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/rapid-oral-fluid-screening-device-market/request-for-sample

 Furthermore, as the technology is becoming easy-to-develop and subject to a smaller number of regulations, the market is witnessing less entry hurdles for new entrants. Additionally, rapid oral fluid has ability to diagnose drug consumed in the body in less than one day and cannabis consumed in less than four hours after the testing time, hence, propelling the growth of rapid oral fluid screening devices, globally over the projected period.

 Rapid oral fluid screening devices provide a wide range of screening abilities such as marijuana, cocaine, methamphetamine, and opioids are expected to drive rapid oral fluid screening device market growth over the forecast period. In addition, the growing need for drug screening across the regions owing to increasing consumption of illegal narcotics is expected to drive the demand for these devices in the coming years.

 Get Discount on this Research Report : https://www.polarismarketresearch.com/industry-analysis/rapid-oral-fluid-screening-device-market/request-for-discount-pricing

 The global rapid oral fluid screening device market players include OraSure Technologies, Inc., Oranoxis Inc., Guangzhou Wondfo Biotech Co., Ltd, UCP Biosciences, Inc., MEDACX Limited, Screen Italia Srl, and AccuBioTech Co. Ltd., among others. Moreover, developing and commercializing products that evaluate adherence to HIV medications, enhancing its product offerings to include additional diagnostic offerings, and building new infrastructure also adds towards the growth of the organizations.

 Read More : https://www.prnewswire.com/news-releases/rapid-oral-fluid-screening-device-market-size-usd-24-08-billion-by-2027--cagr-20-7--polaris-market-research-301212427.html